Bicara Therapeutics Inc (NASDAQ:BCAX) IPO will take place September, 13 on the NASDAQ exchange under the ticker BCAX.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 12, 2025.

See also: Benzinga IPO Calendar

About Bicara Therapeutics Inc

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.